Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: Determining demographic differences in the USA

Ronald S. Go, Herbert C. Heien, Lindsey R. Sangaralingham, Elizabeth B Habermann, Nilay D Shah

Research output: Contribution to journal › Letter

Original languageEnglish (US)
Pages (from-to)e123-e125
JournalHaematologica
Volume103
Issue number3
DOIs
StatePublished - Feb 28 2018

Fingerprint

Monoclonal Gammopathy of Undetermined Significance
Demography
Neoplasms

ASJC Scopus subject areas

  • Hematology

Cite this

Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies : Determining demographic differences in the USA. / Go, Ronald S.; Heien, Herbert C.; Sangaralingham, Lindsey R.; Habermann, Elizabeth B; Shah, Nilay D.

In: Haematologica, Vol. 103, No. 3, 28.02.2018, p. e123-e125.

Research output: Contribution to journal › Letter

Go, RS, Heien, HC, Sangaralingham, LR, Habermann, EB & Shah, ND 2018, 'Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: Determining demographic differences in the USA', Haematologica, vol. 103, no. 3, pp. e123-e125. https://doi.org/10.3324/haematol.2017.179978
Go RS, Heien HC, Sangaralingham LR, Habermann EB, Shah ND. Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: Determining demographic differences in the USA. Haematologica. 2018 Feb 28;103(3):e123-e125. https://doi.org/10.3324/haematol.2017.179978
Go, Ronald S. ; Heien, Herbert C. ; Sangaralingham, Lindsey R. ; Habermann, Elizabeth B ; Shah, Nilay D. / Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies : Determining demographic differences in the USA. In: Haematologica. 2018 ; Vol. 103, No. 3. pp. e123-e125.
@article{56bf7c2febcb459dac2c561884b9098e,
title = "Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: Determining demographic differences in the USA",
author = "Go, {Ronald S.} and Heien, {Herbert C.} and Sangaralingham, {Lindsey R.} and Habermann, {Elizabeth B} and Shah, {Nilay D}",
year = "2018",
month = "2",
day = "28",
doi = "10.3324/haematol.2017.179978",
language = "English (US)",
volume = "103",
pages = "e123--e125",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "3",

}

TY - JOUR

T1 - Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies

T2 - Determining demographic differences in the USA

AU - Go, Ronald S.

AU - Heien, Herbert C.

AU - Sangaralingham, Lindsey R.

AU - Habermann, Elizabeth B

AU - Shah, Nilay D

PY - 2018/2/28

Y1 - 2018/2/28

UR - http://www.scopus.com/inward/record.url?scp=85042754535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042754535&partnerID=8YFLogxK

U2 - 10.3324/haematol.2017.179978

DO - 10.3324/haematol.2017.179978

M3 - Letter

C2 - 29269527

AN - SCOPUS:85042754535

VL - 103

SP - e123-e125

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 3

ER -

Access to Document